Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8EQN

BG505 UFO-E2p-L4P nanoparticle reconstructed by focused refinement with a mask around the nanoparticle core

Summary for 8EQN
Entry DOI10.2210/pdb8eqn/pdb
EMDB information28540 28541 28542 28543
DescriptorBG505 UFO-E2p-L4P (1 entity in total)
Functional Keywordsglycoprotein, bg505, ufo, vaccine design, nanoparticle, protein design, viral protein
Biological sourceHuman immunodeficiency virus 1
Total number of polymer chains1
Total formula weight109370.85
Authors
Antanasijevic, A.,Zhang, Y.N.,Zhu, J.,Ward, A.B. (deposition date: 2022-10-08, release date: 2023-04-19, Last modification date: 2024-06-19)
Primary citationZhang, Y.N.,Paynter, J.,Antanasijevic, A.,Allen, J.D.,Eldad, M.,Lee, Y.Z.,Copps, J.,Newby, M.L.,He, L.,Chavez, D.,Frost, P.,Goodroe, A.,Dutton, J.,Lanford, R.,Chen, C.,Wilson, I.A.,Crispin, M.,Ward, A.B.,Zhu, J.
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidates.
Nat Commun, 14:1985-1985, 2023
Cited by
PubMed Abstract: Uncleaved prefusion-optimized (UFO) design can stabilize diverse HIV-1 envelope glycoproteins (Envs). Single-component, self-assembling protein nanoparticles (1c-SApNP) can display 8 or 20 native-like Env trimers as vaccine candidates. We characterize the biophysical, structural, and antigenic properties of 1c-SApNPs that present the BG505 UFO trimer with wildtype and modified glycans. For 1c-SApNPs, glycan trimming improves recognition of the CD4 binding site without affecting broadly neutralizing antibodies (bNAbs) to major glycan epitopes. In mice, rabbits, and nonhuman primates, glycan trimming increases the frequency of vaccine responders (FVR) and steers antibody responses away from immunodominant glycan holes and glycan patches. The mechanism of vaccine-induced immunity is examined in mice. Compared with the UFO trimer, the multilayered E2p and I3-01v9 1c-SApNPs show 420 times longer retention in lymph node follicles, 20-32 times greater presentation on follicular dendritic cell dendrites, and up-to-4 times stronger germinal center reactions. These findings can inform future HIV-1 vaccine development.
PubMed: 37031217
DOI: 10.1038/s41467-023-37742-z
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.7 Å)
Structure validation

238582

PDB entries from 2025-07-09

PDB statisticsPDBj update infoContact PDBjnumon